CSS
IRMD icon

Cubist Systematic Strategies’s iRadimed IRMD Stock Holding History

Cubist Systematic Strategies’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$591K Buy
+8,298
New +$553K ﹤0.01% 2194
2023
Q3 		– Sell
-6,209
Closed -$296K – 3632
2023
Q2 		$296K Buy
+6,209
New +$280K ﹤0.01% 2641
2022
Q3 		– Sell
-6,113
Closed -$207K – 4571
2022
Q2 		$207K Sell
6,113
-5,555
-48% -$199K ﹤0.01% 3677
2022
Q1 		$523K Buy
11,668
+6,386
+121% +$295K ﹤0.01% 2508
2021
Q4 		$244K Buy
+5,282
New +$213K ﹤0.01% 2935
2016
Q2 		– Sell
-24
Closed – – 1783
2016
Q1 		$0 Sell
24
-1,295
-98% -$24.8K ﹤0.01% 1718
2015
Q4 		$37K Buy
+1,319
New +$37.3K ﹤0.01% 1633

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cubist Systematic Strategies's IRMD Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in iRadimed (IRMD) in Q3 2025: 8,298 shares worth $591K. The stake represents ﹤0.01% of the portfolio and ranks #2194 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in IRMD as recently as Q2 2023.

Cubist Systematic Strategies first reported a position in IRMD in Q4 2015 and has held it in 7 quarters since. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Cubist Systematic Strategies held 8,298 shares of iRadimed worth $591K as of Q3 2025.
  • iRadimed was a new Cubist Systematic Strategies position in Q3 2025.
  • iRadimed made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2194 holding.
  • Cubist Systematic Strategies first reported a position in iRadimed in Q4 2015 and has held it in 7 quarters since.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.